TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
CYTK

Cytokinetics Inc

Healthcare · Biotechnology

64.70$ -1.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Cytokinetics Inc (CYTK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,925 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CYTK
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
741 824 808 1,524 1,436 1,402 1,264 1,226 1,437 1,425 1,273 1,925
561 628 639 1,068 1,019 1,108 956 887 977 917 839 1,208
100 113 120 191 47 95 74 75 225 123 130 255
539 615 619 1,057 1,012 1,076 938 858 963 882 819 1,166
2.5 1.3 0.8 0.0 0.2 17 2.0 8.4 1.8 18 6.8 24
-2.5 – -0.8 – -0.2 – – – – – 0.2 0.4
1,179 1,211 1,204 1,415 1,450 1,537 1,530 1,594 1,958 2,084 2,100 2,098
78 103 89 103 110 180 160 131 142 202 199 181
17 28 30 30 30 30 33 34 38 60 66 48
14 22 13 9.5 12 20 14 16 22 22 25 21
609 607 607 643 644 646 645 713 1,048 1,116 1,118 1,120
-439 -386 -396 109 -14 -135 -266 -369 -521 -660 -827 -173
-1,975 -2,112 -2,248 -2,391 -2,552 -2,702 -2,863 -2,998 -3,304 -3,487 -3,693 -3,892
96 99 102 109 118 118 118 119 120 122 123 132

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?